Vibratory Stimulation for the Treatment of Chronic Pain

Paused · Not applicable · Has a placebo group

Conditions studied: Chronic Pain, Pelvic Pain, Functional Abdominal Pain Syndrome, Low Back Pain, Migraine

In brief

The purpose of this study is to perform a first in man study with VCR stimulation of the belly and back for patients with chronic pain conditions including pelvic pain, functional abdominal pain, or low back pain. This study will also examine VCR stimulation of the temporal region for patients with migraine with or without aura. Additional goals of the study will be to determine the safety, tolerability, and acceptability of VCR stimulation for the treatment of these pain conditions.

Key facts

Study ID

NCT04069572

Run by

Stanford University

People needed

50

Starts

2026-09-01

Expected to finish

2027-12-01

Last updated by the study team

2026-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age greater than or equal to 18 years old.
• Diagnosis of either chronic pelvic pain, functional abdominal pain, axial low back pain, or migraine with or without aura of at least 3 months duration.
• English speaking
• Ability and willingness to complete questionnaires and in-person assessments
• Current average daily pain score of greater than or equal to 4 on the Numeric Rating Scale of Pain (0-10 scale)
• For patients with migraine diagnosis they must report at least 2 headaches in the baseline headache diary in the 30 days preceding randomization.

You may not qualify if…

• Any conditions causing inability to complete assessments (education, cognitive ability, mental status, medical status)
• Any significant psychiatric problems, including acute confusional state (delirium), ongoing psychosis, or clinically significant depression
• Any suicidality as assessed by answer of greater than 0 on question 9 the PHQ-9 assessing suicidal thoughts.
• Any current illicit drug or alcohol abuse.
• Any history of recurrent or unprovoked seizures.
• Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days.
• Pregnancy, breast-feeding or lack of reliable contraception
• Changes in pain medications in the previous 4 weeks
• Implanted electrical stimulation device.
• Skin infection over stimulation sites.
• Any pain interventions in the preceding 6 weeks (epidural steroid injection, sympathetic block, peripheral nerve block, lumbar medial branch blocks) Any botulinum toxin injection in the previous 3 months
• For patients with migraine diagnosis additional exclusion criteria include receipt of preventive anti-migraine treatment in the past 3 months, failure on greater than or equal to 3 well-conducted preventive drug trials, concurrent medication overuse headache diagnosis, and concurrent frequent/chronic tension type headache.
• Frequent/chronic tension type headache

Where it is running

• Stanford Neuroscience Health Center — Palo Alto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.